학술논문
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis
Document Type
Article
Author
Lenk, L.; Heymann, J.; Reimer, C.; Dietterle, A.; Vogiatzi, F.; Alten, J.; Schrappe, M.; Cario, G.; Baccelli, I.; Mary, C.; Corallo, F.; Taurelle, J.; Narbeburu, E.; Neyton, S.; Déramé, M.; Pengam, S.; Poirier, N.; Laqua, A.; Wessels, W.; Brüggemann, M.; Winterberg, D.; Peipp, M.; Bornhauser, B.; Bourquin, J.-P.; Raffel, S.; Dovhan, V.; Schewe, D.M.; Schüler, T.; Escherich, G.; den Boer, M.L.; Boer, J.M.; Antić; Bergmann, A.K.
Source
In: Blood . (Blood, 27 June 2024, 143(26):2735-2748)
Subject
Language
English
ISSN
15280020
00064971
00064971